Ropes & Gray Podcasts

What impact will the incoming Trump administration have on the 2017 health care and life sciences regulatory outlook? In this podcast, Washington, D.C.-based partners Tom Bulleit (health care) and Al Cacozza (life sciences) offer their perspectives on what might lie ahead.

Today we will discuss the recently enacted 21st Century Cures law. This is part of the Capital Insights podcasts series we are hosting to examine the issues and potential regulatory changes emanating from Washington, D.C., as we transition to a new Federal administration.

What impact could the pending Supreme Court argument and decision in TC Heartland v. Kraft have on patent infringement litigation in the United States? With the oral argument scheduled for March 27, Doug Hallward-Driemeier, who leads Ropes & Gray’s Supreme Court and Appellate practice, along with Matt Rizzolo and Sam Brenner from the firm’s Intellectual Property Litigation practice offer their perspectives on the case and what it may mean for venue reform in intellectual property litigation.

In a recently released Ropes & Gray podcast, asset management partner Isabel Dische, tax partner Brett Robbins, and private client partner Cameron Casey discuss the effect of Section 457A on pre-2009 management and incentive fees and charitable planning strategies that can be implemented this year to reduce 2017’s tax burden.

What impact will the incoming Trump administration have on health care enforcement and False Claims Act cases? In this podcast, Colleen Conry and Alex Rene, partners in Ropes & Gray’s government enforcement practice in Washington, D.C., offer their perspectives on what might lie ahead under a new administration.

In this podcast, Doug Hallward-Driemeier, chair of Ropes & Gray’s appellate and Supreme Court practice, moderates a discussion with partner Kellie Combs and senior counsel Alan Bennett about the FDA’s open hearings regarding off-label communications.

In this podcast, Doug Hallward-Driemeier, chair of Ropes & Gray’s appellate and Supreme Court practice, moderates a discussion with life sciences partners Kellie Combs and Greg Levine about three key documents recently issued by the FDA related to manufacturer communications.

What impact will the incoming Trump administration have on securities enforcement? Having previously served with the DOJ, U.S. Attorney’s Office for the Southern District of New York and SEC, respectively, Colleen Conry and Marc Berger from Ropes & Gray’s government enforcement practice and Jeremiah Williams from the firm’s business and securities litigation practice offer their perspectives on what might lie ahead under a new administration.

Ropes & Gray life science partners Gregory Levine (Washington, D.C.), Albert Cacozza (Washington, D.C.) and Michael Beauvais (Boston) cover the latest changes in digital health regulation, investment and transactions, providing insights on disruptive forces, the current and future regulatory landscape, and current and expected investments in the market.